Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SPIRIVA DIN 02246793

Status: Marketed
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 18 MCG
Dosage formCapsule
RouteInhalation
SchedulePRESCRIPTION
ClassHuman
ATCR03BB04 TIOTROPIUM BROMIDE
Original market date21-Nov-2002
Current status date21-Nov-2002
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE)

DINProductCompanyFormStrengthStatus
02550865APO-TIOTROPIUMAPOTEX INCCapsuleTIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 18 MCGMarketed
02441888INSPIOLTO RESPIMATBOEHRINGER INGELHEIM (CANADA) LTD LTEESolutionTIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 2.5 MCG; OLODATEROL (OLODATEROL HYDROCHLORIDE) 2.5 MCGMarketed
02537850LUPIN-TIOTROPIUMLUPIN PHARMA CANADA LIMITEDCapsuleTIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 18 MCGMarketed
02435381SPIRIVA RESPIMATBOEHRINGER INGELHEIM (CANADA) LTD LTEESolutionTIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 2.5 MCGMarketed

Notices of Compliance

NOCDateSubmissionReason
8032002-11-20New Drug Submission (NDS)
Request a quote for SPIRIVA

How to read a Canadian DIN record